| Literature DB >> 27313721 |
Zhihong Dai1, Zhiyu Liu1, Yuren Gao1, Liang Wang1.
Abstract
Ureteral cancer is a rare type of neoplasm, with the most prevalent forms including squamous cell carcinoma, transitional cell carcinoma and adenocarcinoma. Ureteral lymphoma is particularly uncommon, and forming a pre-operative diagnosis of the disease is often difficult. The current study describes the case of a 31-year-old man presenting with a space-occupying lesion located in the left lower ureter. Follicular non-Hodgkin's lymphoma was diagnosed via intraoperative frozen section and post-operative pathological analysis. The affected ureteric segment was excised, and the ureter was repaired by end-to-end anastomosis with insertion of a double-J tube for internal drainage. The patient was followed up for 10 months and presented with no signs of recurrence. The current study affirms the importance of pathological examination in the differential diagnosis of ureteral neoplasms and the selection of an appropriate treatment.Entities:
Keywords: follicular lymphoma; non-Hodgkin's lymphoma; ureter
Year: 2016 PMID: 27313721 PMCID: PMC4888145 DOI: 10.3892/ol.2016.4524
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967
Figure 1.(A) CT scan demonstrating a space-occupying lesion in the lower left ureter. CT value, 22–24 HU. (B) Contrast-enhanced CT scan of the ureter. CT value, 72–82 HU. (C) CT urogram of the ureter (lesion size, 20×16 mm). CT, computed tomography.
Figure 2.Lymphoma resected during the surgery. The lymphoma was a spindle-shaped neoplasm, gray-white in color (measuring 3×1 cm). The affected ureteral mucosa was smooth with integrity.
Figure 3.Post-operative pathological examination. (A) Hematoxylin-eosin staining exhibited atypical lymphocytes from follicular nodules. Immunohistochemical staining demonstrated positive expression for (B) Bcl-2, (C) CD20 and (D) CD3 in the nodular soft-tissue mass located in the left ureter. Magnification, ×200. Bcl-2, B-cell lymphoma 2; CD, cluster of differentiation.
Summary of reported cases of malignant lymphoma of the ureter.
| Author, year | Age, years | Gender | Side | Pathology | Treatment | Outcome, follow-up time | Refs. |
|---|---|---|---|---|---|---|---|
| Schniederjan and Osunkoya, 2009 | 28 | M | R | NHL (DLBCL) | Unknown | SWD, 2.5 years | ( |
| Ni, 2014 | 61 | M | L | NHL (DLBCL) | R-CHOP | NED, 6 months | ( |
| Yoshii, 2010 | 41 | F | R | NHL (DLBCL) | Chemotherapy | SWD, 16 months | ( |
| Kubota, 2007 | 58 | M | L | NHL (DLBCL) | PU + chemotherapy | NED, 2 years | ( |
| 74 | M | Unknown | NHL (DLBCL) | Unknown | Unknown | ( | |
| Bhattachary and Gammall, 1995 | 26 | M | Bil | NHL (DLBCL) | PU + chemotherapy | Unknown | ( |
| Kerner, 2008 | 59 | M | R | NHL (DLBCL) | Unknown | Unknown | ( |
| 42 | M | L | NHL (DLBCL) | R-CHOP | SWD, 2.5 years | ( | |
| 35 | M | L | NHL (MALT) | NU + R-CHOP | NED, 1 year | ( | |
| Numakura, 2011 | 72 | M | R | NHL (MALT) | PU | S, 5 months | ( |
| Haitani, 2012 | 71 | M | R | NHL (follicular) | PU | SND, 3.5 years | ( |
| Kubota, 2007 | 68 | M | Bil | NHL | NU + chemotherapy | S, 3 years | ( |
| Salem, 2014 | 69 | F | L | NHL | PU | SWD, 1 year | ( |
| Jaegar, 2014 | 22 | F | L | NHL | PU | NED,6 months | ( |
| Kubota, 2007 | 60 | M | R | NHL | Unknown | Unknown | ( |
| 38 | M | L | NHL | NU + chemotherapy | NED, 21 months | ( | |
| 52 | F | L | HL | NU + radiation | Unknown | ( | |
| 12 | M | L | HL | NU + chemotherapy | NED, 18 months | ( | |
| 52 | M | L | HL | PU | Unknown | ( | |
| 54 | M | R | HL | NU + chemotherapy | NED, 11 months | ( |
F, female; M, male; R, right; L, left; Bil, bilateral; NHL, non-Hodgkin's lymphoma; DLBCL, diffuse large B-cell lymphoma; MALT, mucosa-associated lymphoid tissue; NU, nephroureterectomy; PU, partial ureterectomy; S, succumbed with unknown disease status; SND, succumbed with no presence of disease; SWD, succumbed to disease; NED, no evidence of disease; R-CHOP, rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone.